Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study

References

• Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten Hi, Pahlman L, Glimelius B, van Krieken JR, Leer JW, van de Velde CJ. Preoperative radio-therapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638–46.
   Google Scholar
• NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. Jaw, 1990; 264: 1444–50.
   PubMed Web of Science ®Google Scholar
• McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995; 10: 126–32.
   Google Scholar
• Radice E, Dozois RR. Locally recurrent rectal cancer. Dig Surg 2001; 18: 355–62.
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002; 95: 1144–50.
   Google Scholar
• Wong R, Thomas G, Cummings B, Froud P, Shelley W, Withers R, Williams J. In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: a systematic review. Int J Radiat Oncol Biol Phys 1998; 40: 437–46.
   Google Scholar
• Rodel C, Grabenbauer GG, Matzel KE, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R. Extensive surgery after high-dose preoperative chemo-radiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000; 43: 312–9.
   Google Scholar
• Harima Y, Nagata K, Harinma K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage III cervical carci-noma. Int j Hyperthermia 2001; 17: 97–105.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–25.
   PubMed Web of Science ®Google Scholar
• Wendtner CM, Abdel-Rahman S, Krych M, Baumert J, Lindner LH, Baur A, Hiddemann W, Issels RD. Response to neoadjuvant chemotherapy combined with regional hyperther-mia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2002; 20: 3156–64.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers 0, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56.
   PubMed Web of Science ®Google Scholar
• Urano M, Kuroda M, Nishimura Y. For the clinical application of themochemotherapy given at mild temperatures. Int J Hyperthermia 1999; 15: 79–107.
   Google Scholar
• Rietbroek RC, van de Vaart PJ, Haveman J, Blommaert FA, Geerdink A, Bakker PJ, Veenhof CH. Hyperthermia enhances the cytotoxicity and platinum-DNA adduct forma-tion of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol 1997; 123: 6–12.
   PubMed Web of Science ®Google Scholar
• Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro. Int J Hyperthermia 2002; 18: 307–15.
   PubMed Web of Science ®Google Scholar
• Hegewisch-Becker S, Gruber Y, Corovic A, Pichlmeier U, Atanackovic D, Nierhaus A, Hossfeld DK. Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated meta-static colorectal cancer: a phase II study. Ann Oncol 2002; 13: 1197–204.
   Google Scholar
• Grothey A, Deschler B, Kroening H, Ridwelski K, Reichardt P, Kretzschmar A, Clemens N, Hirschmann W, Lorenz M, Asperger W, Buechele T, Schmoll H. Phase III study of bolus 5-Fluorouracil/Folinic Acid (Mayo) vs. weekly high-dose 24h 5-FU infusion/Folinic Acid + Oxaliplatin (FUFOX) in advanced colorectal cancer. J Clin Oncol 2002; 19: A512.
   Google Scholar
• Wein A, Riedel C, Bruckl W, Merkel S, Ott R, Hanke B, Baum U, Fuchs F, Gunther K, Reck T, Papadopoulos T, Hahn EG, Hohenberger W. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 2003; 64: 131–8.
   Google Scholar
• Carrato A, Gallego J, Diaz-Rubio E. Oxaliplatin: results in colorectal carcinoma. Crit Rev Oncol Hernatol 2002; 44: 29–44.
   PubMed Web of Science ®Google Scholar
• Maindrault-Goebel F, de Gramont A, Louvet C, Andre T, Carola E, Gilles V, Lotz JP, Tournigand C, Mabro M, Molitor JL, Artru P, Izrael V, Krulik M. Evaluation of oxa-liplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR). Ann Oncol 2000; 11: 1477–83.
   Google Scholar
• van Der Zee J. Heating the patient: a promising approach? Ann Oncol 2002; 13: 1173–84.
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–97.
   PubMed Web of Science ®Google Scholar
• Rau B, Wust P, Hohenberger P, Loffel J, Hunerbein M, Below C, Gellermann J, Speidel A, Vogl T, Riess H, Felix R, Schlag PM. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg 1998; 227: 380–9.
   PubMed Web of Science ®Google Scholar
• Issels R, Prenninger SW, Nagele A, Boehm E, Sauer H, Jauch K-W, Denecke H, Berger H, Peter K, Williams W. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas. J Clin Oncol 1990; 11: 1818–29.
   Google Scholar
• Rau B, Wust P, Tilly W, Gellermann J, Harder C, Riess H, Budach V, Felix R, Schlag PM. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 2000; 48: 381–91.
   Google Scholar
• Tilly W, Wust P, Rau B, Harder C, Gellermann J, Schlag P, Budach V, Felix R. Temperature data and specific absorption rates in pelvic tumors: predicitve factors and correlations. Int J Hypertherrnia 2001; 17: 172–88.
   PubMed Web of Science ®Google Scholar
• Prosnitz L. A new phase III trial for treatment of carcinoma of the cervix. Int J Hypertherrnia 2002; 18: 31–2.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez GD. The Dutch Deep Hyperthermia Trial: results in cervical cancer. Int J Hypertherrnia 2002; 18: 1–12.
   PubMed Web of Science ®Google Scholar
• Jones EL, Samulski TV, Dewhirst MW, Alvarez-Secord A, Berchuck A, Clarke-Pearson D, Havrilesky LJ, Soper J, Prosnitz LR. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 2003; 98: 277–82.
   Google Scholar
• Hildebrandt B, Wust P, Rau B, Schlag PM, Riess H. Regional hyperthermia in rectal cancer. Lancet 2000; 356: 771–2.
   Google Scholar